Role of imaging biomarkers in mutation-driven non-small cell lung cancer-Reference-Cited by-同舟云学术

Role of imaging biomarkers in mutation-driven non-small cell lung cancer

Published:2020-07-24 Issue:7 Volume:11 Page:412-427
ISSN:2218-4333
Container-title:World Journal of Clinical Oncology
language:
Short-container-title:WJCO

Author:

Mendoza Dexter P,Piotrowska Zofia,Lennerz Jochen K,Digumarthy Subba R

Publisher

Baishideng Publishing Group Inc.

Subject

Oncology

Reference97 articles.

1. Global cancer statistics, 2012

2. National Cancer Institute. SEER Cancer Statistics Review (CSR) 1975-2016. [updated 9 April 2020]. Available from: https://seer.cancer.gov/csr/1975_2016/

3. Comprehensive molecular profiling of lung adenocarcinoma

4. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

5. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer;International Journal of Molecular Sciences;2024-02-07

2. Re-Analysis of Non-Small Cell Lung Cancer and Drug Resistance Microarray Datasets with Machine Learning;Cybernetics and Systems;2023-02-02

3. Diagnostic test accuracy of artificial intelligence-based imaging for lung cancer screening: A systematic review and meta-analysis;Lung Cancer;2023-02

4. Molecular Markers in Guiding Lung Cancer Diagnosis and Treatment;Journal of Men's Health;2022-07-28

5. The radiologist’s role in pathologic diagnosis of small lung nodules: radiographic methods of tissue acquisition;Current Challenges in Thoracic Surgery;2021-01